Drupal.behaviors.print = function(context) {window.print();window.close();}>

Alnylam, Max Planck Settle Suit Over Tuschl IP

March 17, 2011

Alnylam, Max Planck Settle Suit Over Tuschl IP

Alnylam said that as part of the agreement, it would allow Merck, the parent company of one-time rival Sirna Therapeutics, to sub-license a portion of the disputed IP to which it previously did not have access.

Full-text access for premium subscribers only. Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.

Related Stories